September 20 & 21, 2023
7:00 – 10:00 PDT/16:00 – 19:00 CEST
Registration link will be set up soon!
Building on the success of our two 2020 virtual events (Special Event “Response to COVID-19” and Meeting V – Zooming into the AIRR Community Meeting), the Meetings Sub-committee has partnered with the Diagnostics Working Group to create a mid-cycle virtual event. This will be a 2-day virtual meeting, with one interactive session day dedicated to the Working Group and Sub-committee achievements and challenges and one day focused on a special Diagnostics session entitled “Bringing AIRR-seq to the clinic – mapping the challenges”.
September 20th, 2023
Working Group and Sub-committee Presentations & Discussions:
- Biological Resources Working Group
- Common Repository Working Group
- Diagnostics Working Group
- Germline Database Working Group
- Legal and Ethics Working Group
- Software Working Group
- Standards Working Group
- Communications Sub-committee
- Executive Sub-committee
- Inferred Allele Review Sub-committee
- Meetings Sub-committee
Strategic Planning Sub-committee hosts an AIRR-C future session.
September 21st, 2023
Since the original vision in 2014, the Adaptive Immune Receptor Repertoire (AIRR) Community has established an extensive network of experimental and computational experts in the use of next-generation sequencing technologies to study antibody/B-cell and T-cell receptor repertoires. The goals of the Community are to develop methods and standards for the generation, analysis and sharing of AIRR-seq data that could become references for academic and industrial research. The Community has already addressed huge challenges and has created protocol recommendations, developed data and metadata standards to accurately describe data and enable the interoperability of software, and collected data in repositories.
A natural next step is to get these products into use in the clinics, which of course comes with additional challenges, as regulatory requirements might apply. Validation and regulatory processes are the backbone of diagnostics and therapeutics. Navigating these processes without appropriate knowledge is daunting at best and may lead to poor decisions and failed projects. The Diagnostics WG is pleased to invite you to “Bringing AIRR-seq to the clinic – mapping the challenges“, a capacity-building session of AIRR Community Special Event 2023 Zooming in to the Community II to unravel the regulatory landscape that could apply to AIRR-seq based products in a clinical setting, from disease monitoring to diagnostics. After a series of talks, a roundtable discussion will bring together experts to highlight different aspects of the regulatory pathways, with a focus on software as a medical device, to help us set off into the unknown…
